In Nov. 2022, the U.S. nonprofit Multidisciplinary Association for Psychedelic research (MAPS) declared that it had concluded a 2nd phase-a few trial on MDMA being a treatment for PTSD—a stage greatly noticed as the https://psychedelicmushroomstores.com/